#1
#1 out of 112.4K est. views89.24%
business2h ago
3 healthcare stock picks from a fund manager up 41% this year
- The Tema Oncology ETF surged about 41% year to date, signaling strong momentum in cancer-focused stocks.
- Fund manager David Song cited Revolution Medicines as the top holding with notable gains since August.
- Roche Holdings was praised for its cancer immunology portfolio and attractive valuation around a 15 PE ratio.
- Guardant Health was highlighted for its liquid biopsy test aimed at early cancer detection and monitoring.
- The article notes healthcare has outperformed tech since September as investors seek defensive assets.
- Tema Oncology ETF (CANC) led gains within its sector, reflecting focus on cancer treatment equities.
- Biotech leadership and clinical progress were framed as key drivers behind stock movements.
- The report emphasizes continued upside from Roche's breast cancer readout and pipeline.
- Analyst notes emphasize the potential of Guardant Health’s diagnostic approach in colorectal cancer.
- The piece frames healthcare as a defensive, outperformance-focused sector for investors.
Vote 1